Ameriprise’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-116,228
| Closed | -$11.3M | – | 4099 |
|
|
2015
Q1 | $11.3M | Sell |
116,228
-25,545
| -18% | -$2.49M | 0.01% | 1456 |
|
|
2014
Q4 | $13.2M | Buy |
141,773
+180
| +0.1% | +$16.7K | 0.01% | 1280 |
|
|
2014
Q3 | $9.74M | Sell |
141,593
-19,420
| -12% | -$1.34M | 0.01% | 1493 |
|
|
2014
Q2 | $16.9M | Buy |
161,013
+29,229
| +22% | +$3.06M | 0.01% | 1149 |
|
|
2014
Q1 | $10.9M | Buy |
131,784
+3,744
| +3% | +$311K | 0.01% | 1432 |
|
|
2013
Q4 | $8.29M | Sell |
128,040
-8,025
| -6% | -$519K | 0.01% | 1639 |
|
|
2013
Q3 | $8.61M | Buy |
136,065
+21,438
| +19% | +$1.36M | 0.01% | 1568 |
|
|
2013
Q2 | $4.82M | Buy |
+114,627
| New | +$4.82M | ﹤0.01% | 1904 |
|